Aurobindo Pharma Shareholding Pattern & Promoter Holding

Pharmaceuticals & Biotechnology · Latest pattern: Sep 2026

As of Sep 2026, promoters hold 51.88% of Aurobindo Pharma, FIIs hold 17.41%, DIIs hold 24.37% and the public holds 6.29%. Promoter holding was unchanged from Jun 2026.

Get an alert when Aurobindo Pharma reports results or its shareholding changes. Free account.

Promoters

51.88%

unchanged QoQ

FIIs

17.41%

+1.03 pp QoQ

DIIs

24.37%

−0.68 pp QoQ

Public

6.29%

−0.34 pp QoQ

Aurobindo Pharma shareholding, quarter by quarter

QuarterPromotersFIIsDIIsGovernmentPublicShareholders
Sep 202651.88%17.41%24.37%0.05%6.29%2,33,737
Jun 202651.88%16.38%25.05%0.05%6.63%2,39,073
Mar 202651.82%15.24%25.82%0.05%7.08%2,41,298
Dec 202551.82%13.95%27.66%0.03%6.55%2,36,859
Sep 202551.82%14.21%27.60%0.00%6.37%2,47,662
Jun 202551.82%14.38%26.93%0.00%6.88%2,72,208
Mar 202551.82%15.33%26.23%0.00%6.61%2,69,323
Dec 202451.82%16.29%25.21%0.00%6.67%2,57,962
Sep 202451.82%16.59%25.14%0.00%6.45%2,48,488
Jun 202451.80%16.73%24.77%0.00%6.69%2,38,622
Mar 202451.84%18.01%23.28%0.00%6.87%2,44,575
Dec 202351.84%20.72%20.60%0.00%6.85%2,41,944

Promoters · FIIs (foreign institutions) · DIIs (domestic institutions) · Government · Public (retail & others). Percentages of total shares, from the quarterly pattern filed with the exchanges.

Value of the promoter stake

At a market capitalisation of ₹1.05 lakh cr, the promoter group's 51.88% stake is worth ₹54.51k cr. A promoter group is usually a family, trust or holding company; this figure covers only this listed company and is not anyone's net worth.

Promoter holding in Pharmaceuticals & Biotechnology peers

Aurobindo Pharma shareholding: common questions

What is the promoter holding in Aurobindo Pharma?

Promoters hold 51.88% of Aurobindo Pharma as of Sep 2026. Their stake was unchanged from Jun 2026.

How much do FIIs hold in Aurobindo Pharma?

Foreign institutional investors (FIIs) held 17.41% of Aurobindo Pharma in Sep 2026, +1.03 pp versus Jun 2026.

How much do mutual funds and other DIIs hold in Aurobindo Pharma?

Domestic institutional investors (DIIs), which include mutual funds and insurers, held 24.37% of Aurobindo Pharma in Sep 2026, −0.68 pp versus Jun 2026.

Is the promoter holding in Aurobindo Pharma pledged?

The latest disclosed shareholding pattern shows no pledged promoter shares in Aurobindo Pharma.

How has Aurobindo Pharma's promoter holding changed in the last year?

Promoter holding moved from 51.82% in Sep 2025 to 51.88% in Sep 2026 (+0.06 pp).

How many shareholders does Aurobindo Pharma have?

Aurobindo Pharma had 2,33,737 shareholders in Sep 2026, compared with 2,39,073 in Jun 2026.